Cargando…
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
Lassa virus (LASV), a mammarenavirus, infects an estimated 100,000–300,000 individuals yearly in western Africa and frequently causes lethal disease. Currently, no LASV-specific antivirals or vaccines are commercially available for prevention or treatment of Lassa fever, the disease caused by LASV....
Autores principales: | Caì, Yíngyún, Iwasaki, Masaharu, Beitzel, Brett F., Yú, Shuīqìng, Postnikova, Elena N., Cubitt, Beatrice, DeWald, Lisa Evans, Radoshitzky, Sheli R., Bollinger, Laura, Jahrling, Peter B., Palacios, Gustavo F., de la Torre, Juan C., Kuhn, Jens H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266387/ https://www.ncbi.nlm.nih.gov/pubmed/30463334 http://dx.doi.org/10.3390/v10110655 |
Ejemplares similares
-
CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection
por: Caì, Yíngyún, et al.
Publicado: (2014) -
A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region
por: Cai, Yingyun, et al.
Publicado: (2020) -
Development and Characterization of a cDNA-Launch Recombinant Simian Hemorrhagic Fever Virus Expressing Enhanced Green Fluorescent Protein: ORF 2b’ Is Not Required for In Vitro Virus Replication
por: Cai, Yingyun, et al.
Publicado: (2021) -
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
por: Cai, Yingyun, et al.
Publicado: (2020) -
An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells
por: Cai, Yingyun, et al.
Publicado: (2021)